Androgen receptor expression on circulating tumor cells in metastatic breast cancer
Takeo Fujii(The University of Texas MD Anderson Cancer Center), Naoto T. Ueno(University of Hawaiʻi at Mānoa)
Cited by 22
Related Papers
Acquired Resistance to Erlotinib in A-431 Epidermoid Cancer Cells Requires Down-regulation of MMAC1/PTEN and Up-regulation of Phosphorylated Akt
|Cancer Research|2007|115
Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity
|Molecular Cancer Therapeutics|2007|81
PEA-15 Inhibits Tumorigenesis in an MDA-MB-468 Triple-Negative Breast Cancer Xenograft Model through Increased Cytoplasmic Localization of Activated Extracellular Signal-Regulated Kinase
|Clinical Cancer Research|2010|64
Birinapant Enhances Gemcitabine's Antitumor Efficacy in Triple-Negative Breast Cancer by Inducing Intrinsic Pathway–Dependent Apoptosis
|Molecular Cancer Therapeutics|2020|33
The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer
|Journal of Experimental & Clinical Cancer Research|2024|24